European Journal of Health Economics

Article	Citations
Do renewable energy and health expenditures improve load capacity factor in the USA and Japan? A new approach to environmental issues	118
COVID-19 and income inequality in OECD countries	93
Are regions equal in adversity? A spatial analysis of spread and dynamics of COVID-19 in Europe	55
The COVID-19 crisis and telework: a research survey on experiences, expectations and hopes	54
Determinants of willingness to pay for health services: a systematic review of contingent valuation studies	45
Comparison of ARIMA, ETS, NNAR, TBATS and hybrid models to forecast the second wave of COVID-19 hospitalizations in Italy	43
Estimation of the cost-effective threshold of a quality-adjusted life year in China based on the value of statistical life	42
The economic burden of obesity in Italy: a cost-of-illness study	41
Health effects from heat waves in France: an economic evaluation	36
More room for telemedicine after COVID-19: lessons for primary care?	35
COVID-19 and the role of inequality in French regional departments	30
General population normative data for the EQ-5D-3L in the five largest European economies	28
Efficiency and productivity of health systems in prevention and control of non-communicable diseases in China, 2008–2015	28
Self vs. other, child vs. adult. An experimental comparison of valuation perspectives for valuation of EQ-5D-Y-3L health states	26
The remarkably frequent use of EQ-5D in non-economic research	25
Effect of financial inclusion on out-of-pocket health expenditure: empirics from Ghana	23
Is stronger religious faith associated with a greater willingness to take the COVID-19 vaccine? Evidence from Israel and Japan	22
Disease burden and economic impact of diagnosed non-alcoholic steatohepatitis (NASH) in the United Kingdom (UK) in 2018	22
What is the best approach to adopt for identifying the domains for a new measure of health, social care and carer-related quality of life to measure quality-adjusted life years? Application to the dev	21
Cost effectiveness of breast cancer screening and prevention: a systematic review with a focus on risk-adapted strategies	21
Health state utility values by cancer stage: a systematic literature review	21
Does the universal medical insurance system reduce catastrophic health expenditure among middle-aged and elderly households in China? A longitudinal analysis	21
Measuring health-related quality of life and well-being: a head-to-head psychometric comparison of the EQ-5D-5L, ReQoL-UI and ICECAP-A	21
Evaluating the psychometric properties of the EQ-5D-5L and SF-6D among patients with haemophilia	20
Patient-caregiver agreement and test–retest reliability of the EQ-5D-Y-3L and EQ-5D-Y-5L in paediatric patients with haematological malignancies	20

Comparison of the three-level and the five-level versions of the EQ-5D	19
Preferences for COVID-19 epidemic control measures among French adults: a discrete choice experiment	19
A guide to extending and implementing generalized risk-adjusted cost-effectiveness (GRACE)	18
Testing measurement properties of two EQ-5D youth versions and KIDSCREEN-10 in China	18
Economic analysis of open versus laparoscopic versus robotic hepatectomy: a systematic review and meta-analysis	18
Machine learning versus regression modelling in predicting individual healthcare costs from a representative sample of the nationwide claims database in France	17
The impact of COVID-19 pandemic on insurance demand: the case of China	17
Economics of mental well-being: a prospective study estimating associated health care costs and sickness benefit transfers in Denmark	17
Willingness to pay for a quality-adjusted life year: a systematic review with meta-regression	17
The relationship between renewable energy use and health expenditures in EU countries	17
Value-based pricing for advanced therapy medicinal products: emerging affordability solutions	16
The economic burden of amyotrophic lateral sclerosis: a systematic review	16
Evaluation of the cost-utility of phosphate binders as a treatment option for hyperphosphatemia in chronic kidney disease patients: a systematic review and meta-analysis of the economic evaluations	16
The Italian NHS at regional level: same in theory, different in practice	16
Coverage with evidence development schemes for medical devices in Europe: characteristics and challenges	16
Has the development of cancer biomarkers to guide treatment improved health outcomes?	15
Reassessing the impact of health expenditure on income growth in the face of the global sanitary crisis: the case of developing countries	15
Can the Covid19 pandemic affect the achievement of the ‘Zero Hunger’ goal? Some preliminary reflections	15
Work ethics, stay-at-home measures and COVID-19 diffusion	15
A cost-effectiveness analysis of pembrolizumab with or without chemotherapy for the treatment of patients with metastatic, non-squamous non-small cell lung cancer and high PD-L1 expression in Switzerl	15
Income level and antibiotic misuse: a systematic review and dose–response meta-analysis	14
Does socioeconomic status affect hospital utilization and health outcomes of chronic disease patients?	14
COVID-19 health policy evaluation: integrating health and economic perspectives with a data envelopment analysis approach	14
The cost of lost productivity due to premature mortality associated with COVID-19: a Pan-European study	14
The effect of mental and physical health problems on sickness absence	14
Income and conversion handicaps: estimating the impact of child chronic illness/disability on family income and the extra cost of child chronic illness/child disability in Ireland using a standard of	14
Cost-effectiveness and budget impact of venetoclax in combination with rituximab in relapsed/refractory chronic lymphocytic leukemia in Switzerland	14
Value drivers of development stage biopharma companies	13
Can drones save lives and money? An economic evaluation of airborne delivery of automated external defibrillators	13
Long-term cost of breast cancer treatment to the United States Medicare Program by stage at diagnosis	13
Special FDA designations for drug development: orphan, fast track, accelerated approval, priority review, and breakthrough therapy	13
The causal impact of sugar taxes on soft drink sales: evidence from France and Hungary	13
EQ-5D-5L Portuguese population norms	13
Comparing the psychometric properties of the EQ-5D-3L and EQ-5D-5L descriptive systems and utilities in atopic dermatitis	13
The impact of social health insurance on rural populations	13
Whole exome sequencing in molecular diagnostics of cancer decreases over time: evidence from a cost analysis in the French setting	12
Timing of non-pharmaceutical interventions to mitigate COVID-19 transmission and their effects on mobility: a cross-country analysis	12
Reliability and validity of using EQ-5D-5L among healthy and adolescents with major mental health disorders in Ethiopia	12
The association between bed occupancy rates and hospital quality in the English National Health Service	12
Economic evidence with respect to cost-effectiveness of the transitional care model among geriatric patients discharged from hospital to home: a systematic review	12
Cost-effectiveness of the latent tuberculosis screening program for migrants in Stockholm Region	12
Cost-minimization analysis of immunoglobulin treatment of primary immunodeficiency diseases in Spain	12
Were we happy and we didn’t know it? A subjective dynamic and financial assessment pre-, during and post-COVID-19	11
European union regulation of health technology assessment: what is required for it to succeed?	11
The impact of decentralisation on the performance of health care systems: a non-linear relationship	11
The common interests of health protection and the economy: evidence from scenario calculations of COVID-19 containment policies	11
Ageing and health care expenditures: the importance of age per se, steepening of the individual-level expenditure curve, and the role of morbidity	11
The residential healthcare for the elderly in Italy: some considerations for post-COVID-19 policies	11
The effect of alcohol tax changes on retail prices: how do on-trade alcohol retailers pass through tax changes to consumers?	11
The economics of alternative payment models for pharmaceuticals	11

Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) statement: updated reporting guidance for health economic evaluations	10
Cost-effectiveness of metabolic surgery for the treatment of type 2 diabetes and obesity: a systematic review of economic evaluations	10
General practice in the EU: countries you see, customs you find	10
Evaluating the conduct and application of health utility studies: a review of critical appraisal tools and reporting checklists	10
Psychometric performance of proxy-reported EQ-5D youth version 5-level (EQ-5D-Y-5L) in comparison with three-level (EQ-5D-Y-3L) in children and adolescents with scoliosis	10
Validation of the PAM-13 instrument in the Hungarian general population 40 years old and above	10
Cost–utility analysis of risk-reducing strategies to prevent breast and ovarian cancer in BRCA-mutation carriers in Switzerland	10
EQ-5D-5L: a value set for Romania	10
Economic and social cost of epilepsy in Poland: 5-year analysis	10
Business cycle and mortality in Spain	9
Mapping PedsQL™ Generic Core Scales to EQ-5D-3L utility scores in transfusion-dependent thalassemia patients	9
Can competition improve hospital quality of care? A difference-in-differences approach to evaluate the effect of increasing quality transparency on hospital quality	9
A European multinational cost-effectiveness analysis of empagliflozin in heart failure with reduced ejection fraction	9
Mapping MacNew Heart Disease Quality of Life Questionnaire onto country-specific EQ-5D-5L utility scores: a comparison of traditional regression models with a machine learning technique	9
Assessing the cost-effectiveness of COVID-19 vaccines in a low incidence and low mortality setting: the case of Thailand at start of the pandemic	9
Cost-effectiveness of screening smokers and ex-smokers for lung cancer in the Netherlands in different age groups	9
Willingness to provide informal care to older adults in Germany: a discrete choice experiment	9
Voluntary private health insurance, health-related behaviours and health outcomes: evidence from Russia	9
Comparing EQ-5D-3L and EQ-5D-5L in measuring the HRQoL burden of 4 health conditions in China	9
Population norms in France with EQ-5D-5L: health states, value indexes, and VAS	9
Willingness-to-pay for cancer treatment and outcome: a systematic review	9
Consideration of quality of life in the health technology assessments of rare disease treatments	9
The cost-effectiveness of unilateral cochlear implants in UK adults	8
Population preferences for non-pharmaceutical interventions to control the SARS-CoV-2 pandemic: trade-offs among public health, individual rights, and economics	8
Real-world study of direct medical and indirect costs and time spent in healthcare in patients with chronic graft versus host disease	8
The impact of nurse staffing levels on nursing-sensitive patient outcomes: a multilevel regression approach	8
The effects of patient cost-sharing on health expenditure and health among older people: Heterogeneity across income groups	8
Adjusted productivity costs of stroke by human capital and friction cost methods: a Northern Finland Birth Cohort 1966 study	8
Complexities of health and acceptance of electronic health records for the Austrian elderly population	8
Does voluntary health insurance improve health and longevity? Evidence from European OECD countries	8
The impact on quality of life of diet restrictions and disease symptoms associated with phenylketonuria: a time trade-off and discrete choice experiment study	8
Future medical and non-medical costs and their impact on the cost-effectiveness of life-prolonging interventions: a comparison of five European countries	8
Communities and testing for COVID-19	8
Costs and management of patients with hemophilia A in France: the Hemraude study	8
Cost-effectiveness of the MitraClip device in German heart failure patients with secondary mitral regurgitation	7
Effects of establishing a financing scheme for outpatient care on inpatient services: empirical evidence from a quasi-experiment in China	7
The cost-effectiveness of transcatheter aortic valve implantation: exploring the Italian National Health System perspective and different patient risk groups	7
Canada population norms for the EQ-5D-5L	7
Time and lexicographic preferences in the valuation of EQ-5D-Y with time trade-off methodology	7
Social costs of obesity in the Czech Republic	7
Developing an Australian utility value set for the Early Childhood Oral Health Impact Scale-4D (ECOHIS-4D) using a discrete choice experiment	7
Personalized diabetes management: what do patients with diabetes mellitus prefer? A discrete choice experiment	7
Financial risk allocation and provider incentives in hospital–insurer contracts in The Netherlands	7
The impact of inpatient bed capacity on length of stay	7
The effect of influenza and pneumococcal vaccination in the elderly on health service utilisation and costs: a claims data-based cohort study	7
The goal of risk equalization in regulated competitive health insurance markets	7
Inequality, public health, and COVID-19: an analysis of the Spanish case by municipalities	7
Obesity and metabolic state are associated with increased healthcare resource and medication use and costs: a Finnish population-based study	7
Regional medical practice variation in high-cost healthcare services	7
Production losses due to mortality associated with modifiable health risk factors in Poland	7
The impact of taxing sugar-sweetened beverages on cola purchasing in Catalonia: an approach to causal inference with time series cross-sectional data	6
Model parameters influencing the cost-effectiveness of sacubitril/valsartan in heart failure: evidence from a systematic literature review	6
A hearing bolt-on item increased the measurement properties of the EQ-5D-5L in a community-based hearing loss screening program	6
Patient-reported measures: how useful in health economics?	6
Risky business, healthy lives: how risk perception, risk preferences and information influence consumer’s risky health choices	6
Insurance coverage, long-term care utilization, and health outcomes	6
On the correlation between outcome indicators and the structure and process indicators used to proxy them in public health care reporting	6
Accreditation as a quality-improving policy tool: family planning, maternal health, and child health in Egypt	6
Retirement, social support and mental well-being: a couple-level analysis	6
Does compulsory schooling affect health? Evidence from ambulatory claims data	6
Multi-layer health insurance coverage, medical services use and health in a Universal National Health System, the case of Portugal	6
Towards compatibility of EUnetHTA JCA methodology and German HTA: a systematic comparison and recommendations from an industry perspective	6
Different levels of care for follow-up of adults with congenital heart disease: a cost analysis scrutinizing the impact on medical costs, hospitalizations, and emergency department visits	6
Equity in healthcare utilization in Canada’s publicly funded health system: 2000–2014	6
Impact of Long COVID on productivity and informal caregiving	6
Public preferences for policies promoting a healthy diet: a discrete choice experiment	6
A comprehensive review of official discount rates in guidelines of health economic evaluations over time: the trends and roots	5
Estimating the willingness-to-pay to avoid the consequences of foodborne illnesses: a discrete choice experiment	5
Health measures and long-term care use in the European frail population	5
Significant healthcare burden and life cost of spinal muscular atrophy: real-world data	5
Measuring the acceptability of EQ-5D-3L health states for different ages: a new adaptive survey methodology	5
Human papillomavirus in Italy: retrospective cohort analysis and preliminary vaccination effect from real-world data	5
A systematic review of the cost-effectiveness of renal replacement therapies, and consequences for decision-making in the end-stage renal disease treatment pathway	5
Comparative performance and mapping algorithms between EQ-5D-5L and SF-6Dv2 among the Chinese general population	5
Did the COVID-19 pandemic change the willingness to pay for an early warning system for infectious diseases in Europe?	5
Costing methodologies in European economic evaluation guidelines: commonalities and divergences	5
Online and offline health information seeking and the demand for physician services	5
Does health technology assessment compromise access to pharmaceuticals?	5
Comparison of EQ-5D-5L and EORTC QLU-C10D utilities in gastric cancer patients	5
Analysis of oncological drugs authorised in Spain in the last decade: association between clinical benefit and reimbursement	5

Risk, time preferences, trustworthiness and COVID-19 preventive behavior: evidence from France	4
“The reputation premium”: does hospital ranking improvement lead to a higher healthcare spending?	4
Quality of life and healthcare costs of patients with allergic respiratory diseases: a cross-sectional study	4
Mapping of head and neck cancer patient concerns inventory scores on to Euroqol-Five Dimensions-Five Levels (EQ-5D-5L) health utility scores	4
COVID-19: not the time for health economists? A plea for more proactive health economic involvement	4
The impact of cost-sharing on prescription drug demand: evidence from a double-difference regression kink design	4
Factors related to the change in Swiss inpatient costs by disease: a 6-factor decomposition	4
Estimating loss in capability wellbeing in the first year of the COVID-19 pandemic: a cross-sectional study of the general adult population in the UK, Australia and the Netherlands	4
Obesity Kuznets curve and the reality of eco-income ellipsoids (EIE)	4
Economic evaluation of a complex intervention (Engager) for prisoners with common mental health problems, near to and after release: a cost-utility and cost-consequences analysis	4
Does a free maternity policy in Kenya work? Impact and cost–benefit consideration based on demographic health survey data	4
Live and let live: understanding the temporal drivers and spillovers of life expectancy in Europe for public planning	4
Estimating the additional costs of living with a disability in the United Kingdom between 2013 and 2016	4
The attractiveness of jobs in the German care sector: results of a factorial survey	4
The pass-through of excise taxes to market prices of heated tobacco products (HTPs) and cigarettes: a cross-country analysis	4
The cost of chemotherapy administration: a systematic review and meta-analysis	4
The contribution of resident physicians to hospital productivity	4
Structural factors and integrated care interventions: is there a role for economists in the policy debate?	4
Health-economic evaluation of collaborative orthogeriatric care for patients with a hip fracture in Germany: a retrospective cohort study using health and long-term care insurance claims data	4
Adoption of large-scale medical equipment: the impact of competition in the German inpatient sector	4
Does the inclusion of societal costs change the economic evaluations recommendations? A systematic review for multiple sclerosis disease	4
Assessing the treatment pattern, health care resource utilisation, and economic burden of multiple myeloma in France using the Système National des Données de Santé (SNDS) database: a retrospective co	4
Discounting in economic evaluation of healthcare interventions: what about the risk term?	4
Comparing the measurement properties of the ICECAP-A and ICECAP-O instruments in ages 50–70: a cross-sectional study on a representative sample of the Hungarian general population	4
The trade-off between health system resiliency and efficiency: evidence from COVID-19 in European regions	4
Using the EQ-5D-5L to investigate quality-of-life impacts of disease-modifying therapy policies for people with multiple sclerosis (MS) in New Zealand	4
Using fees to reduce bed-blocking: a game between hospitals and long-term care providers	4
Recovery of suspended reimbursements of high-cost drugs subjected to monitoring registries and negotiated agreements (MEAs): a tool for governance and clinical appropriateness in the Italian reality	4
Mass media coverage and vaccination uptake: evidence from the demand for meningococcal vaccinations in Hungary	4
Do preferences differ based on respondent experience of a health issue and its treatment? A case study using a public health intervention	4
Does competition improve hospital performance: a DEA based evaluation from the Netherlands	4
Lifetime direct healthcare costs of treating colorectal cancer: a systematic review	4
Does the amount of formal care affect informal care? Evidence among over-60s in France	4
The impact of ambulatory care spending, continuity and processes of care on ambulatory care sensitive hospitalizations	4
Bayesian modeling of health state preferences: could borrowing strength from existing countries’ valuations produce better estimates	4
Hospital resource utilisation from HPV-related diseases in England: a real-world cost analysis	4
Public health policies for the common interest: rethinking EU states’ incentives strategies when a pandemic reshuffles all interests	4
Assessing Taiwan’s pay-for-performance program for diabetes care: a cost–benefit net value approach	4
Evolution of health care utilization and expenditure during the year before death in 2015 among people with cancer: French snds-based cohort study	3
The effect of duration and time preference on the gap between adult and child health state valuations in time trade-off	3
Mapping the obesity problems scale to the SF-6D: results based on the Scandinavian Obesity Surgery Registry (SOReg)	3
Generating EQ-5D-5L health utility scores from BASDAI and BASFI: a mapping study in patients with axial spondyloarthritis using longitudinal UK registry data	3
Driving time drives the hospital choice: choice models for pelvic organ prolapse surgery in Italy	3
Is it too expensive to fight cancer? Analysis of incremental costs and benefits of the Croatian National Plan Against Cancer	3
Adapting preference-based utility measures to capture the impact of cancer treatment-related symptoms	3
Valuing informal carers’ quality of life using best-worst scaling—Finnish preference weights for the Adult Social Care Outcomes Toolkit for carers (ASCOT-Carer)	3
A novel mathematical model for prioritization of individuals to receive vaccine considering governmental health protocols	3
Cost-effectiveness analysis of (accelerated) pre-operative versus (conventional) post-operative radiotherapy for patients with oral cavity cancer in Sweden	3
Looking into the black box of “Medical Innovation”: rising health expenditures by illness type	3
The impacts of working from home on individual health and well-being	3
The application of discrete choice experiments eliciting young peoples’ preferences for healthcare: a systematic literature review	3
Psychometric evaluation of the German version of the Recovering Quality of Life (ReQoL) measures in patients with affective disorders	3
The EORTC QLU-C10D is a valid cancer-specific preference-based measure for cost-utility and health technology assessment in the Netherlands	3
Does a working day keep the doctor away? A critical review of the impact of unemployment and job insecurity on health and social care utilisation	3
The handling of missing data in trial-based economic evaluations: should data be multiply imputed prior to longitudinal linear mixed-model analyses?	3
Healthcare resource utilization and associated cost of patients with bone metastases from solid tumors who are naïve to bone-targeting agents: a comparative analysis of patients with and without skele	3
Country-level effects of diagnosis-related groups: evidence from Germany’s comprehensive reform of hospital payments	3
Informal care at old age at home and in nursing homes: determinants and economic value	3
Trust me; I know what I am doing investigating the effect of choice list elicitation and domain-relevant training on preference reversals in decision making for others	3
The long-term cost-effectiveness of once-weekly semaglutide 1 mg vs. dulaglutide 3 mg and 4.5 mg in the UK	3
Out-of-pocket expenses of patients with inflammatory bowel disease: a comparison of patient-reported outcomes across 12 European countries	3
Are costs derived from diagnosis-related groups suitable for use in economic evaluations? A comparison across nine European countries in the European Healthcare and Social Cost Database	3
How the COVID-19 pandemic can distort risk adjustment of health plan payment	3
Should administrative costs in health insurance be included in the risk-equalization? An analysis of five countries	3
Value appropriation in hepatitis C	3
Optimising the impact of COVID-19 vaccination on mortality and hospitalisations using an individual additive risk measuring approach based on a risk adjustment scheme	3
A dynamic Markov model to assess the cost-effectiveness of the Kidney Team at Home intervention in The Netherlands	3
Psychometric properties and general population reference values for PROMIS Global Health in Hungary	3
Tenders for generics and biosimilars: a challenging purchasing policy	2
Does NICE influence the adoption and uptake of generics in the UK?	2
German tariffs for the ICECAP-Supportive Care Measure (ICECAP-SCM) for use in economic evaluations at the end of life	2
The cost-effectiveness of a uniform versus age-based threshold for one-off screening for prevention of cardiovascular disease	2
Healthcare costs of diabetic foot disease in Italy: estimates for event and state costs	2
Disutility of injectable therapies in obesity and type 2 diabetes mellitus: general population preferences in the UK, Canada, and China	2
Challenges for health systems seeking to embrace virtual health care for population health	2
Pragmatic randomized controlled trial comparing a complex telemedicine-based intervention with usual care in patients with chronic conditions	2
Infections, accidents and nursing overtime in a neonatal intensive care unit	2
Characteristics and health care costs in patients with a diagnostic imaging for low back pain in Switzerland	2
Disclosing the ‘Big C’: what does cancer survivorship signal to employers?	2
The ‘welcomed lockdown’ hypothesis? Mental wellbeing and mobility restrictions	2
On spillovers in economic evaluations: definition, mapping review and research agenda	2
Assessing validity of the EQ-5D-5L proxy in children and adolescents with Duchenne muscular dystrophy or spinal muscular atrophy	2
Mapping of the acromegaly quality of life questionnaire to ED-5D-5L index score among patients with acromegaly	2
The estimation of health state utility values in rare diseases: do the approaches in submissions for NICE technology appraisals reflect the existing literature? A scoping review	2
Catastrophic household expenditure associated with out-of-pocket payments for dental healthcare in Spain	2
Modeling the potential efficiency of a blood biomarker-based tool to guide pre-hospital thrombolytic therapy in stroke patients	2
Resource utilization and disaggregated cost analysis of bariatric surgery in the Australian public healthcare system	2
Modeling European health systems: a theoretical exercise	2
The costs of celiac disease: a contingent valuation in Switzerland	2
HIT-6 and EQ-5D-5L in patients with migraine: assessment of common latent constructs and development of a mapping algorithm	2
Decision thresholds with genetic testing	2
Cost-effectiveness analysis of vaborem for the treatment of carbapenem-resistant Enterobacteriaceae-Klebsiella pneumoniae carbapenemase (CRE-KPC) infections in the UK	2
Are long-term care jobs harmful? Evidence from Germany	2
Cost and cost-effectiveness of four different SARS-CoV-2 active surveillance strategies: evidence from a randomised control trial in Germany	2
Out-of-pocket costs sustained in the last 12 months by cancer patients: an Italian survey-based study on individual expenses between 2017 and 2018	2